Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

Last Close
Jun 14 04:00PM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)-39.78 Insider Own3.19% Shs Outstand1.34M Perf Week-5.30%
Market Cap3.35M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float1.30M Perf Month-43.10%
Income-32.67M PEG- EPS next Q- Inst Own3.46% Short Float2.86% Perf Quarter-48.02%
Sales3.42M P/S0.98 EPS this Y- Inst Trans- Short Ratio0.21 Perf Half Y-32.94%
Book/sh-9.02 P/B- EPS next Y- ROA-235.91% Short Interest0.04M Perf Year-57.91%
Cash/sh0.86 P/C2.91 EPS next 5Y- ROE-314.91% 52W Range1.65 - 38.40 Perf YTD-40.48%
Dividend Est.- P/FCF- EPS past 5Y65.83% ROI- 52W High-93.49% Beta-0.65
Dividend TTM- Quick Ratio0.14 Sales past 5Y6.61% Gross Margin-2.65% 52W Low51.52% ATR (14)0.35
Dividend Ex-Date- Current Ratio0.14 EPS Y/Y TTM73.88% Oper. Margin-458.95% RSI (14)30.39 Volatility6.91% 11.26%
Employees- Debt/Eq- Sales Y/Y TTM31.11% Profit Margin-955.69% Recom3.00 Target Price30.00
Option/ShortNo / Yes LT Debt/Eq- EPS Q/Q65.69% Payout- Rel Volume0.05 Prev Close2.49
Sales Surprise-22.33% EPS Surprise-6.98% Sales Q/Q48.24% Earnings- Avg Volume178.24K Price2.50
SMA20-21.59% SMA50-46.39% SMA200-44.83% Trades Volume9,387 Change0.40%
Date Action Analyst Rating Change Price Target Change
Mar-01-19Initiated Alliance Global Partners Buy $2.30
Feb-07-18Reiterated H.C. Wainwright Buy $1 → $9
Jun-29-16Initiated Rodman & Renshaw Buy $2.50
Jun-05-24 09:53AM
May-24-24 04:05PM
May-16-24 07:00AM
Apr-29-24 04:05PM
Apr-24-24 06:22AM
04:15PM Loading…
Apr-23-24 04:15PM
Mar-25-24 04:05PM
Mar-08-24 04:20PM
Nov-14-23 04:30PM
Oct-12-23 12:32PM
Sep-29-23 08:22AM
Aug-13-23 07:46AM
Aug-11-23 06:18AM
04:15PM Loading…
Aug-10-23 04:15PM
Aug-07-23 07:30AM
Aug-03-23 08:00AM
Jul-19-23 07:30AM
Jun-26-23 07:30AM
Jun-22-23 07:30AM
Jun-20-23 07:30AM
May-16-23 06:43AM
May-15-23 04:15PM
May-08-23 07:30AM
May-04-23 04:30PM
May-01-23 09:00PM
Apr-26-23 04:30PM
Apr-19-23 08:38AM
04:30PM Loading…
Apr-18-23 04:30PM
Apr-05-23 07:30AM
Apr-03-23 07:30AM
Apr-01-23 10:44PM
Mar-30-23 02:25PM
Mar-29-23 04:15PM
Mar-22-23 07:30AM
Mar-01-23 07:30AM
Feb-17-23 07:30AM
Jan-26-23 07:30AM
Jan-18-23 07:30AM
Jan-17-23 07:30AM
Jan-11-23 04:30PM
Jan-06-23 08:00PM
Jan-04-23 04:30PM
Dec-13-22 09:44AM
Nov-10-22 04:10PM
Oct-27-22 07:30AM
Oct-25-22 07:30AM
Oct-03-22 04:20PM
Sep-30-22 08:38AM
Sep-20-22 07:30AM
Sep-06-22 07:30AM
Aug-31-22 07:30AM
Aug-25-22 07:30AM
Aug-11-22 04:15PM
Jul-28-22 07:30AM
Jul-26-22 07:30AM
Jul-08-22 07:30AM
Jun-27-22 11:22PM
Jun-22-22 08:00AM
Jun-09-22 07:30AM
May-26-22 07:30AM
May-12-22 05:35PM
Apr-28-22 07:30AM
Apr-25-22 07:30AM
Apr-20-22 07:30AM
Apr-06-22 07:30AM
Apr-05-22 07:30AM
Mar-29-22 07:25PM
Mar-24-22 07:05PM
Mar-15-22 07:30AM
Feb-28-22 07:55PM
Feb-10-22 04:30PM
Jan-18-22 07:30AM
Jan-10-22 07:30AM
Dec-14-21 07:30AM
Dec-08-21 04:30PM
Nov-30-21 08:45AM
Nov-11-21 04:05PM
Nov-04-21 03:01PM
Oct-28-21 07:30AM
Oct-21-21 07:30AM
Oct-18-21 04:30PM
Oct-14-21 08:00AM
Oct-05-21 05:17AM
Oct-04-21 02:59PM
OpGen, Inc. is a precision medicine company harnessing the power of molecular diagnostics and informatics to help combat infectious disease. It engages in the development of molecular information products and services for global healthcare settings. The firm's also offers guidance to clinicians about life threatening infections, improving patient outcomes, and decreasing the spread of infections caused by multidrug-resistant microorganisms. Its products include Unyvero, Acuitas AMR Gene Panel and Acuitas Lighthouse, and the ARES Technology Platform including ARESdb, using NGS technology and AI-powered bioinformatics solutions for antibiotic response prediction. The company was founded on January 22, 2001 and is headquartered in Gaithersburg, MD.